Belite Bio BLTE
NASDAQ BLTE
$166.66 -3.16 (-1.86%)
As of: Oct 1, 2026 · 12:51 PM EDT

Belite Bio (BLTE) Securities - Held-to-maturity (2024 - 2025)

Updated

Belite Bio (BLTE) reported Securities - Held-to-maturity of -$451.99 million for Q4 2025, compared with -$183.77 million a year earlier.

Analysis

Belite Bio (BLTE) Securities - Held-to-maturity (2024 - 2025) Analysis & Trends

Dating back to Q3 2024, Belite Bio's Securities - Held-to-maturity record includes 4 quarters.

  • By year, Securities - Held-to-maturity came in at -$183.77 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Belite Bio 6.68 Bn 6.68 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -451.99 Mn
Sep 30, 2025 118.58 Mn
Dec 31, 2024 -183.77 Mn
Sep 30, 2024 -120.81 Mn
API Access

Belite Bio Securities - Held-to-maturity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=securities-held-to-maturity&ticker=BLTE&period=max&api_key=YOUR_API_KEY